Skip to main content
. 2019 Jul 2;160(10):2367–2387. doi: 10.1210/en.2019-00194

Table 5.

mRNA Expression in Skeletal Muscle

Genes Sig. M Veh M Cort F Veh F Cort
GR, MR, and GR target genes
 Nr3c1 1.00 ± 0.17 0.90 ± 0.06 0.88 ± 0.20 0.91 ± 0.15
 Fkbp5 S,C,× 1.00 ± 0.10 18.11 ± 1.06a 0.69 ± 0.13 12.49 ± 2.29a,b
 Tsc22d3 C 1.00 ± 0.20 3.99 ± 0.67a 1.07 ± 0.21 4.30 ± 0.95a
 Nr3c2 1.00 ± 0.10 1.36 ± 0.29 1.22 ± 0.34 1.21 ± 0.13
Muscle atrophy
 Foxo1 C 1.00 ± 0.13 12.80 ± 2.11a 1.30 ± 0.30 14.25 ± 3.46a
 Klf15 C 1.00 ± 0.18 2.70 ± 0.63a 1.22 ± 0.24 2.23 ± 0.36
Glucose transport
 Irs1 S,C,× 1.00 ± 0.17 0.66 ± 0.10 2.24 ± 0.45b 0.61 ± 0.19a
 Slc2a1 1.00 ± 0.27 1.60 ± 0.61 1.08 ± 0.13 0.81 ± 0.26
 Slc2a4 1.00 ± 0.08 1.04 ± 0.09 1.01 ± 0.16 1.24 ± 0.12
 Chrebpb C 1.00 ± 0.35 13.06 ± 1.22a 0.80 ± 0.06 18.04 ± 10.57a

Gene expression was normalized to Gapdh and Rn18s expression and expressed relative to the vehicle-treated male mice. Sig. indicates significant effects (P < 0.05) analyzed with two-way ANOVA.

Abbreviations: C, corticosterone treatment; S, sex; ×, interaction of corticosterone treatment and sex.

a

P < 0.05, for effect of corticosterone treatment in mice of the same sex, by post hoc test.

b

P < 0.05, for sex difference between mice with the same treatment, by post hoc test.